Cardiohepatic interactions in heart failure: an overview and clinical implications
- PMID: 23603231
- DOI: 10.1016/j.jacc.2013.03.042
Cardiohepatic interactions in heart failure: an overview and clinical implications
Abstract
Heart failure (HF) is a major public health problem leading to frequent hospitalizations, impaired quality of life, and shortened life expectancy. Heart failure leads to a chronic inability to meet metabolic requirements of end organs or skeletal muscle. Current literature lacks comprehensive descriptions of HF effects on hepatic function. In this review paper, we summarize the literature that is available in hopes of highlighting the key differences in clinical presentation, histological findings, and biochemical profiles of patients who present with both acute and chronic liver injury secondary to HF. We further discuss the use of liver function tests as prognostic markers in patients with HF, as well as the implications of liver injury on drug metabolism in this patient population. Finally, we provide recommendations regarding the management of both types of liver injury in HF patients.
Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Similar articles
-
How to interpret liver function tests in heart failure patients?Turk J Gastroenterol. 2015 May;26(3):197-203. doi: 10.5152/tjg.2015.0086. Turk J Gastroenterol. 2015. PMID: 26006191 Review.
-
Cardiohepatic syndrome: liver injury in decompensated heart failure.Curr Heart Fail Rep. 2014 Sep;11(3):236-40. doi: 10.1007/s11897-014-0206-8. Curr Heart Fail Rep. 2014. PMID: 24890902 Review.
-
[Liver in heart failure].Vnitr Lek. 2014 Apr;60(4):298-303. Vnitr Lek. 2014. PMID: 24985988 Review. Czech.
-
[Cardio-hepatic Syndrome in Heart Failure: Prevalence, Pathogenesis and Prognostic Significance].Kardiologiia. 2016 Dec;56(12):63-71. Kardiologiia. 2016. PMID: 28290806 Review. Russian.
-
Cardiohepatic Interactions: Implications for Management in Advanced Heart Failure.Heart Fail Clin. 2016 Jul;12(3):349-61. doi: 10.1016/j.hfc.2016.03.011. Heart Fail Clin. 2016. PMID: 27371512 Review.
Cited by
-
The value of phenylalanine in predicting atrial fibrillation risk in chronic heart failure.Front Cardiovasc Med. 2024 Aug 20;11:1392548. doi: 10.3389/fcvm.2024.1392548. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39228663 Free PMC article.
-
Kidney Dysfunction, Hepatic Impairment, and Lipid Metabolism Abnormalities in Patients with Precapillary Pulmonary Hypertension.Diagnostics (Basel). 2024 Aug 21;14(16):1824. doi: 10.3390/diagnostics14161824. Diagnostics (Basel). 2024. PMID: 39202312 Free PMC article.
-
Candidate Screening for Heart Failure With Preserved Ejection Fraction Clinic by Fib-4 Index From Subclinical Subjects.Gastro Hep Adv. 2022 Sep 21;2(2):170-181. doi: 10.1016/j.gastha.2022.09.005. eCollection 2023. Gastro Hep Adv. 2022. PMID: 39132617 Free PMC article.
-
A Novel Liver Fibrosis Marker FIB-5 Index Predicted Response to Cardiac Resynchronization Therapy and Prognostic Outcomes in Patients With Heart Failure.Ann Noninvasive Electrocardiol. 2024 Sep;29(5):e70004. doi: 10.1111/anec.70004. Ann Noninvasive Electrocardiol. 2024. PMID: 39101582 Free PMC article.
-
Noninvasive Monitoring of Severe Pulmonary Artery Hypertension in Atrial Septal Defect Patients: Role of Serum Bilirubin Combined with Uric Acid.Rev Cardiovasc Med. 2024 Jan 29;25(2):50. doi: 10.31083/j.rcm2502050. eCollection 2024 Feb. Rev Cardiovasc Med. 2024. PMID: 39077349 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
